91 – 100 of 236
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
The impact of a quadrivalent human papillomavirus (types 6, 11, 16, 18) virus-like particle vaccine in European women aged 16 to 24
- Contribution to journal › Article
-
Mark
Maternal smoking during pregnancy and testicular cancer in the sons: A nested case-control study and a meta-analysis
- Contribution to journal › Article
-
Mark
Is Smoking an Independent Risk Factor for Invasive Cervical Cancer? A Nested Case-Control Study Within Nordic Biobanks
- Contribution to journal › Article
-
Mark
Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate
- Contribution to journal › Scientific review
-
Mark
Endogenous steroid hormone levels in early pregnancy and risk of testicular cancer in the offspring: A nested case-referent study
- Contribution to journal › Article
-
Mark
Modified General Primer PCR System for Sensitive Detection of Multiple Types of Oncogenic Human Papillomavirus
- Contribution to journal › Article
-
Mark
A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions
- Contribution to journal › Article
-
Mark
Male Circumcision and Serologically Determined Human Papillomavirus Infection in a Birth Cohort
- Contribution to journal › Article
-
Mark
EUROCOURSE: towards optimisation of the use of cancer registries for scientific excellence in cancer research in Europe: an FP7 ERA-net project
(2009) 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology In EJC Supplements 7(2). p.201-202
- Contribution to journal › Published meeting abstract
-
Mark
The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16-26 Years
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding